Cramer Chats With Alkermes CEO Richard Pops

Thursday, 10 May 2012 | 6:49 PM ET
Alkermes CEO on Profits & New Drugs
Richard Pops, Alkermes CEO, discusses getting FDA approval for developing better drugs, with Mad Money's Cramer.

Although there is some downside risk, young companies with big ideas can deliver big returns, said Jim Cramer on CNBC's "Mad Money." There is probably no better place to look for these companies than in biotechnology sector, he continued, citing Alkermes as an example of an interesting speculative stock.

Based in Dublin, Alkermes develops drugs that primarily address disorders pertaining to the central nervous system, such as addiction, schizophrenia and depression. Cramer wanted to learn more about the company and its future prospects, so he welcomed CEO Richard Pops onto Thursday's program.

Watch the video to see the complete conversation!

Call Cramer: 1-800-743-CNBC

Questions for Cramer? madmoney@cnbc.com

Questions, comments, suggestions for the Mad Money website? madcap@cnbc.com

  Price   Change %Change

Contact Mad Money

  • Showtimes

    Monday - Friday 6p ET
  • Jim Cramer is host of CNBC's "Mad Money" and co-anchor of the 9 a.m. ET hour of CNBC's "Squawk on the Street."

Mad Money Features

  • Grab the latest CNBC gear from the NBCUniversal Store!

  • Get a behind-the-scenes look at how Cramer formulates his investment advice. "Inside the Madness" is a column, which features e-mails and more with Cramer and his researcher Nicole Urken.

  • You’ve always wanted to hit the “Hallelujah!” button. Here’s your chance.